The store will not work correctly when cookies are disabled.
3-((2-chloro-4-(trifluoromethyl)phenoxy)methyl)-N-phenylbenzamide
ID: ALA4860115
PubChem CID: 155154021
Max Phase: Preclinical
Molecular Formula: C21H15ClF3NO2
Molecular Weight: 405.80
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1)c1cccc(COc2ccc(C(F)(F)F)cc2Cl)c1
Standard InChI: InChI=1S/C21H15ClF3NO2/c22-18-12-16(21(23,24)25)9-10-19(18)28-13-14-5-4-6-15(11-14)20(27)26-17-7-2-1-3-8-17/h1-12H,13H2,(H,26,27)
Standard InChI Key: MMPLAVIITNNMJR-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
28.9428 -10.0044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9417 -10.8239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6497 -11.2329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3594 -10.8234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3566 -10.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6479 -9.5955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0627 -9.5895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7720 -9.9954 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.4781 -9.5842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1858 -9.9935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8915 -9.5829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8888 -8.7649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1746 -8.3591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4719 -8.7720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7611 -8.3689 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
34.5945 -8.3527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3042 -8.7576 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.5903 -7.5355 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
35.3002 -7.9367 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
28.2350 -9.5959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2348 -8.7787 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.5274 -10.0047 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.8196 -9.5963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8231 -8.7785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1161 -8.3701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4075 -8.7790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4103 -9.6004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1179 -10.0050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
14 15 1 0
12 16 1 0
16 17 1 0
16 18 1 0
16 19 1 0
1 20 1 0
20 21 2 0
20 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 405.80 | Molecular Weight (Monoisotopic): 405.0743 | AlogP: 6.19 | #Rotatable Bonds: 5 |
Polar Surface Area: 38.33 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 6.11 | CX LogD: 6.11 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.55 | Np Likeness Score: -1.62 |
References
1. (2020) Modulators of mas-related g-protein receptor x4 and related products and methods, |